Health Care Select Sector SPDR (XLV)

At A Glance

You hold XLV in 0 portfolios

Price

128.04USD

 -3.29 -2.51%

4:00pm EDT

Category
Sector Equity
YTD Return (Cumulative)
 -9.12%
Classification
Health/Biotech
3 Year Return (Annualized)
 15.49%
52 Week High
$143.42
52 Week Low
$120.61
Lipper Leader Profile (Overall)
Total Return
Consistent Return
Capital Preservation
Low Expense
Tax Efficiency(U.S. only)

Holdings Diversification »

Asset Class

 
100% Stocks
 
0% Cash

Key Statistics

Total Net Assets$36.91B
Total Stock Holdings66
Total Bond Holdings0
% Foreign Stocks0%
Portfolio Turnover Rate4%

Fund Characteristics

XLV's equity holdings have an average USD dollar-weighted market cap of $203.69 billion, a weighted average price/earnings of 29.6x, and an average price/book of 8.3x.

Geographic Exposure

Country Exposure

 
3% Ireland
 
97% Remainder

Top Holdings (as of Mar 31, 2022)

Market Cap

 
 
89%Mega Cap
11%Large Cap

Concentration

52.6% concentration in Top 10 Holdings
20.1% concentration in next 10 holdings
27.1% concentration in the remainder of the holdings
Top 10 Holdings% of Assets
(Change vs 1Q Ago)
Recent
News
Reuters
Reports
1
UNH
9.2%
(+2.6%)
2
JNJ
8.9%
(+6.9%)
20
3
PFE
5.6%
(+3.3%)
20
4
ABBV.K
5.5%
(+6.1%)
16
5
TMO
4.5%
(+0.8%)
6
LLY
4.4%
(+22.7%)
7
ABT
4.0%
(-7.4%)
20
8
MRK
4.0%
(+20.4%)
20
9
DHR
3.6%
(-7.0%)
10
BMY
3.1%
(+15.7%)
14
1 - 10 of 20

Top Sectors

 
89% Health Care
 
5% Industrials
 
4% Consumer Services
 
2% Remainder

Latest News for XLV Holdings

1:04pm EDT

(Fixes typographical error in third paragraph)</p>

By Michael Erman>

May 18 (Reuters) - The U.S. National Institutes of Health is in talks with Pfizer Inc ab...

12:20pm EDT

(Recasts with expanding booster eligibility, adds quotes)

By Ahmed Aboulenein and Jeff Mason

WASHINGTON, May 18 (Reuters) - Health officials are conside...

10:29am EDT

May 18 (Reuters) - EMA:

* EMA: EMA STARTED EVALUATING AN APPLICATION FOR THE USE OF A BOOSTER DOSE OF PFIZER/BIONTECH'S COVID-19 VACCINE, COMIRNATY, IN...

3:00am EDT

* Demand for COVID shots drops in Africa as supply rises

* Countries turn to mobile campaigns to boost uptake

* Africa, average age 20, has fared better...

2:56am EDT

By Soo-hyang Choi

<p>SEOUL, May 18 (Reuters) - As North Korea battles its first known COVID outbreak, a lack of storage, chronic power shortages and inade...

6:12pm EDT

(Recasts with rising cases, adds expert quotes)

By Ahmed Aboulenein

WASHINGTON, May 17 (Reuters) - Rising COVID-19 cases are driving up the use of thera...

4:34pm EDT

(Adds comment from news conference)

By Chris Gallagher

WASHINGTON, May 17 (Reuters) - U.S. House Democrats on Tuesday unveiled a bill to provide $28 mil...

4:09pm EDT

(Adds quotes, antiviral supply data, COVID-19 data, background)

By Ahmed Aboulenein

WASHINGTON, May 17 (Reuters) - Use of Pfizer Inc's COVID-19 oral ant...

2:40pm EDT

WASHINGTON, May 17 (Reuters) - Use of Pfizer Inc's COVID-19 oral antiviral treatment Paxlovid has jumped 315% over the past four weeks, the U.S. Depar...

1:13pm EDT

May 17 (Reuters) - The nationwide shortage of baby formula has prompted the United States to temporarily allow foreign imports from other suppliers, w...

View Overview Page For